News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
News Conference News TCT 2021 Failed MitraClip Is Uncommon, but Bleak When It Happens Michael O'Riordan October 08, 2021
News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2019 EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG Marcus A. Banks September 28, 2019
News Conference News TCT 2019 Surgical Volume Matters When It Comes to Repair of Primary MR Todd Neale September 28, 2019
News Conference News TCT 2018 PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes Michael O'Riordan September 25, 2018
News Conference News TCT 2018 EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis Michael O'Riordan September 21, 2018
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
News Conference News TCT 2017 No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy Michael O'Riordan October 30, 2017
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
News Conference News TCT 2015 Trial Results Often Struggle to Keep Pace With Evolving Technology Nicole Lou October 13, 2015